Clinical, radiological and immunohistological distinctions between limbic-predominant and typical Alzheimer’s disease: A systematic review
Journal of Biomedical and Clinical Research · 01.04.2026 · 19 · 153-172
DOI: 10.3897/jbcr.e183988 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Biomedical and Clinical Research, online erschienen am 01.04.2026. Verfasst von Guilherme Linha Secco und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is the leading cause of dementia worldwide, with prominent hippocampal and medial temporal lobe atrophy. Limbic-predominant (LP) AD has been proposed as a distinct subtype, but distinctions from typical AD remain unclear. This systematic review evaluates clinical, radiological, and immunohistological differences between LP and typical AD.
Methods
Following PRISMA guidelines, PubMed, Embase, and Web of Science were searched. Data on baseline characteristics, clinical, radiological, and immunohistological features were extracted. Screening was performed with Rayyan.ai, and study quality was assessed using the Newcastle–Ottawa Scale.
Results
From 211 articles, 21 studies were included, totaling 11,315 patients: 1,178 (15.7%) LP, 4,159 (36.7%) typical AD, and 5,378 (47.6%) other presentations. Weighted averages: education 24.31 years (LP) vs. 17.15 years (AD); age at onset 77.36 years (LP) vs. 72.33 years (AD); disease duration 8.43 years (LP) vs. 8.95 years (AD). Clinical presentations were similar, with cognitive impairment and memory deficits predominant. MRI and FDG-PET revealed lower hippocampal volume and higher metabolism in LP. Tau-PET showed lower R2 relaxation in parietal, cingulate, and cuneus regions and elevated hippocampal neurofibrillary tangles. Immunohistology revealed higher hippocampal tau burden and more TDP-43 inclusions in LP compared to typical AD.
Conclusion
LP and typical AD exhibit notable radiological and immunohistological differences, though clinical presentations overlap. Current evidence cannot definitively classify LP as a distinct subtype or separate disease. Further studies are required to clarify these distinctions.
Zitieren
APA
Secco, G. L., Lachman, L. R., Oliveira, L. A. D., Caramujo, M. B., Campos, L. G. G., Carvalho, A. B. D., Castro, G. M. N. D., Malinoski, F. H., Christoff, C. D. O., & Silva, M. C. M. D. (2026). Clinical, radiological and immunohistological distinctions between limbic-predominant and typical Alzheimer’s disease: A systematic review. Journal of Biomedical and Clinical Research, 19, 153-172. https://doi.org/10.3897/jbcr.e183988
Vancouver
Secco GL, Lachman LR, Oliveira LAD, Caramujo MB, Campos LGG, Carvalho ABD, et al. Clinical, radiological and immunohistological distinctions between limbic-predominant and typical Alzheimer’s disease: A systematic review. Journal of Biomedical and Clinical Research. 2026;19:153-172. doi:10.3897/jbcr.e183988
BibTeX
@article{Secco2026,
author = {Secco, Guilherme Linha and Lachman, Lucas Ribas and Oliveira, Leticia Alves de and Caramujo, Maisa Baldinu and Campos, Lunna Giovanna Gonçalves and Carvalho, Alana Barroso de and Castro, Giovanna Moreira Nascimento de and Malinoski, Fábio Henrique and Christoff, Caroline de Oliveira and Silva, Mateus Cordeiro Merlim da},
title = {Clinical, radiological and immunohistological distinctions between limbic-predominant and typical Alzheimer’s disease: A systematic review},
journal = {Journal of Biomedical and Clinical Research},
year = {2026},
volume = {19},
pages = {153--172},
doi = {10.3897/jbcr.e183988}
}
EUVIMED